Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Clinical Trial Management (CTM) Market by Delivery Mode (Web-based CTM, On-premise, and Cloud-based CTM), Product Type (Enterprise-based and Site-based), Component (Software, Hardware, and Services), and End Users (Pharmaceutical and Biopharmaceutical Companies, Clinical Research Organizations, and Healthcare Providers): Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_182575

Pages: 214

Formats:

Feb 2018 | 2640 Views

Charts: 32

Tables: 126

Author(s): Tenzin Kunsel and Onkar Sumant

Purchase Option


Clinical Trial Management Market Overview:

Clinical trials are usually conducted to test the efficacy and safety of any new product ranging from drugs to medical devices. Clinical trial management (CTM) systems utilize different models of simulation and regression to store and interpret the vast amount of unstructured data generated during different clinical trials. These systems help maintain and manage clinical trials conducted by different pharmaceutical companies and clinical research organization. In addition, these systems make it easier to track and monitor the participants involved in the trial, site selection, identify & enroll different subjects, and analyze vast amount of data. The analysis of these data helps in deciding the safety parameters of the product undergoing clinical trial. The global clinical trial management market was valued at $570 million in 2016, and is estimated to reach $1,371 million by 2023, registering a CAGR of 13.4% from 2017 to 2023.

Get more information on this report : Request Sample Pages

Rise in the number of clinical trials owing to the large demand for novel therapeutic drugs and medical devices drive the growth of the market. Moreover, the increase in prevalence of chronic diseases, surge in the trend of outsourcing of clinical trials, and increase in awareness regarding the benefits of using CTM fuels the growth of the clinical trial management market. However, high cost associated with CTM and dearth of skilled professionals hamper the market growth.

Component Segment Review

Based on the component, it is divided into hardware, software, and services. Software is the dominant segment in the CTM market due to the availability of advanced software that make it easier to use and improve the efficiency and productivity of the researchers.

Get more information on this report : Request Sample Pages

Product Type Segment Review

Based on product type, it is bifurcated into enterprise-based and site-based. Enterprise-based system is the dominant segment as they are equipped with special in-house software capabilities. However, site-based CTM systems are expected to be fastest growing segment.

Get more information on this report : Request Sample Pages

Global Clinical Trial Management Market: Key Geographic Segment

Based on region, the clinical trial management market is divided into North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the clinical trial management market in 2016, and is expected to retain its dominance throughout the forecast period.

Get more information on this report : Request Sample Pages

The key players operating in the global clinical trial management market include Oracle, Medidata Solutions, Parexel, BioClinica, Inc., Bio-Optronics, IBM, MedNet Solutions, Veeva Systems, Forte Research Systems, and Merge Healthcare Incorporated.

Other prominent players in the value chain include Mednet Solutions, Arisglobal, eClinForce Inc., DZS Software Solutions, DSG, Inc., Guger Technologies Inc., ICON, Plc., ChemWare Inc., and iWeb Technologies Limited.

Key Benefits for Stakeholders

  • This report entails a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities.
  • Market estimations are based on comprehensive analysis of the key developments in the industry.
  • The global market is comprehensively analyzed with respect to product, delivery mode, component, end user, and region.
  • In-depth analysis based on geography assists in understanding the regional market to assist in strategic business planning.
  • The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.

Clinical Trial Management Market Key Segments:

By Delivery Mode

  • Web-based CTMS
  • On-premise
  • Cloud-based CTMS

By Product Type

  • Enterprise-based
  • Site-based

By Component

  • Software
  • Hardware
  • Services

By End Users

  • Pharmaceutical and Biopharmaceutical Companies
  • Clinical Research Organizations
  • Healthcare Providers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key findings

3.2.1. Top Investment Pockets

3.3. Top player positioning, 2016
3.4. Porter’s five forces analysis
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Rise in the number of clinical trials
3.5.1.2. Increase in trend of outsourcing of clinical trials
3.5.1.3. Increase in prevalence of chronic diseases
3.5.1.4. Increase in awareness regarding the benefits of using CTM

3.5.2. Restrains

3.5.2.1. High cost and data security issues
3.5.2.2. Dearth of qualified and skilled healthcare professionals

3.5.3. Opportunities

3.5.3.1. Increase in R&D activities and expenditure to implement CTM

CHAPTER 4: CLINICAL TRIAL MANAGEMENT MARKET BY DELIVERY MODE

4.1. Overview

4.1.1. Market Size and Forecast

4.2. Web-based

4.2.1. Key market trends & growth opportunities
4.2.2. Market Size and Forecast
4.2.3. Market Analysis, by Country

4.3. On-premise

4.3.1. Key market trends & growth opportunities
4.3.2. Market Size and Forecast
4.3.3. Market Analysis, by Country

4.4. Cloud-based

4.4.1. Key market trends & growth opportunities
4.4.2. Market Size and Forecast
4.4.3. Market Analysis, by Country

CHAPTER 5: CLINICAL TRIAL MANAGEMENT MARKET BY PRODUCT TYPE

5.1. Overview

5.1.1. Market Size and Forecast

5.2. Enterprise-based CTM

5.2.1. Market Size and Forecast
5.2.2. Market Analysis, by Country

5.3. Site-based

5.3.1. Market Size and Forecast
5.3.2. Market Analysis, by Country

CHAPTER 6: CLINICAL TRIAL MANAGEMENT MARKET BY COMPONENT

6.1. Overview

6.1.1. Market Size and Forecast

6.2. Software

6.2.1. Market Size and Forecast
6.2.2. Market Analysis, by Country

6.3. Hardware

6.3.1. Market Size and Forecast
6.3.2. Market Analysis, by Country

6.4. Services

6.4.1. Market Size and Forecast
6.4.2. Market Analysis, by Country

CHAPTER 7: CLINICAL TRIAL MANAGEMENT MARKET BY END USERS

7.1. Overview

7.1.1. Market Size and Forecast

7.2. Pharmaceutical and Biopharmaceutical Companies

7.2.1. Market Size and Forecast
7.2.2. Market Analysis, by Country

7.3. Clinical Research Organizations

7.3.1. Market Size and Forecast
7.3.2. Market Analysis, by Country

7.4. Healthcare Providers

7.4.1. Market Size and Forecast
7.4.2. Market Analysis, by Country

CHAPTER 8: CLINICAL TRIAL MANAGEMENT MARKET BY REGION

8.1. Overview

8.1.1. Market Size and Forecast

8.2. North America

8.2.1. Key Market Trends and Opportunities
8.2.2. Market Size and Forecast, by Product Type
8.2.3. Market Size and Forecast, by Delivery Mode
8.2.4. Market Size and Forecast, by Component
8.2.5. Market Size and Forecast, by End Users
8.2.6. Market Size and Forecast, by Country

8.2.6.1. U.S. Market Size and Forecast, by Product Type
8.2.6.2. U.S. Market Size and Forecast, by Delivery Mode
8.2.6.3. U.S. Market Size and Forecast, by Component
8.2.6.4. U.S. Market Size and Forecast, by End Users
8.2.6.5. Canada Market Size and Forecast, by Product Type
8.2.6.6. Canada Market Size and Forecast, by Delivery Mode
8.2.6.7. Canada Market Size and Forecast, by Component
8.2.6.8. Canada Market Size and Forecast, by End Users
8.2.6.9. Mexico Market Size and Forecast, by Product Type
8.2.6.10. Mexico Market Size and Forecast, by Delivery Mode
8.2.6.11. Mexico Market Size and Forecast, by Component
8.2.6.12. Mexico Market Size and Forecast, by End Users

8.3. Europe

8.3.1. Key Market Trends and Opportunities
8.3.2. Market Size and Forecast, by Product Type
8.3.3. Market Size and Forecast, by Delivery Mode
8.3.4. Market Size and Forecast, by Component
8.3.5. Market Size and Forecast, by End Users
8.3.6. Market Size and Forecast, by Country

8.3.6.1. Germany Market Size and Forecast, by Product Type
8.3.6.2. Germany Market Size and Forecast, by Delivery Mode
8.3.6.3. Germany Market Size and Forecast, by Component
8.3.6.4. Germany Market Size and Forecast, by End Users
8.3.6.5. France Market Size and Forecast, by Product Type
8.3.6.6. France Market Size and Forecast, by Delivery Mode
8.3.6.7. France Market Size and Forecast, by Component
8.3.6.8. France Market Size and Forecast, by End Users
8.3.6.9. UK Market Size and Forecast, by Product Type
8.3.6.10. UK Market Size and Forecast, by Delivery Mode
8.3.6.11. UK Market Size and Forecast, by Component
8.3.6.12. UK Market Size and Forecast, by End Users
8.3.6.13. Italy Market Size and Forecast, by Product Type
8.3.6.14. Italy Market Size and Forecast, by Delivery Mode
8.3.6.15. Italy Market Size and Forecast, by Component
8.3.6.16. Italy Market Size and Forecast, by End Users
8.3.6.17. Spain Market Size and Forecast, by Product Type
8.3.6.18. Spain Market Size and Forecast, by Delivery Mode
8.3.6.19. Spain Market Size and Forecast, by Component
8.3.6.20. Spain Market Size and Forecast, by End Users
8.3.6.21. Rest of Europe Market Size and Forecast, by Product Type
8.3.6.22. Rest of Europe Market Size and Forecast, by Delivery Mode
8.3.6.23. Rest of Europe Market Size and Forecast, by Component
8.3.6.24. Rest of Europe Market Size and Forecast, by End Users

8.4. Asia-Pacific

8.4.1. Key Market Trends and Opportunities
8.4.2. Market Size and Forecast, by Product Type
8.4.3. Market Size and Forecast, by Delivery Mode
8.4.4. Market Size and Forecast, by Component
8.4.5. Market Size and Forecast, by End Users
8.4.6. Market Size and Forecast, by Country

8.4.6.1. Japan Market Size and Forecast, by Product Type
8.4.6.2. Japan Market Size and Forecast, by Delivery Mode
8.4.6.3. Japan Market Size and Forecast, by Component
8.4.6.4. Japan Market Size and Forecast, by End Users
8.4.6.5. China Market Size and Forecast, by Product Type
8.4.6.6. China Market Size and Forecast, by Delivery Mode
8.4.6.7. China Market Size and Forecast, by Component
8.4.6.8. China Market Size and Forecast, by End Users
8.4.6.9. Australia Market Size and Forecast, by Product Type
8.4.6.10. Australia Market Size and Forecast, by Delivery Mode
8.4.6.11. Australia Market Size and Forecast, by Component
8.4.6.12. Australia Market Size and Forecast, by End Users
8.4.6.13. India Market Size and Forecast, by Product Type
8.4.6.14. India Market Size and Forecast, by Delivery Mode
8.4.6.15. India Market Size and Forecast, by Component
8.4.6.16. India Market Size and Forecast, by End Users
8.4.6.17. South Korea Market Size and Forecast, by Product Type
8.4.6.18. South Korea Market Size and Forecast, by Delivery Mode
8.4.6.19. South Korea Market Size and Forecast, by Component
8.4.6.20. South Korea Market Size and Forecast, by End Users
8.4.6.21. Rest of Asia-Pacific Market Size and Forecast, by Product Type
8.4.6.22. Rest of Asia-Pacific Market Size and Forecast, by Delivery Mode
8.4.6.23. Rest of Asia-Pacific Market Size and Forecast, by Component
8.4.6.24. Rest of Asia-Pacific Market Size and Forecast, by End Users

8.5. LAMEA

8.5.1. Key Market Trends and Opportunities
8.5.2. Market Size and Forecast, by Product Type
8.5.3. Market Size and Forecast, by Delivery Mode
8.5.4. Market Size and Forecast, by Component
8.5.5. Market Size and Forecast, by End Users
8.5.6. Market Size and Forecast, by Country

8.5.6.1. Brazil Market Size and Forecast, by Product Type
8.5.6.2. Brazil Market Size and Forecast, by Delivery Mode
8.5.6.3. Brazil Market Size and Forecast, by Component
8.5.6.4. Brazil Market Size and Forecast, by End Users
8.5.6.5. Saudi Arabia Market Size and Forecast, by Product Type
8.5.6.6. Saudi Arabia Market Size and Forecast, by Delivery Mode
8.5.6.7. Saudi Arabia Market Size and Forecast, by Component
8.5.6.8. Saudi Arabia Market Size and Forecast, by End Users
8.5.6.9. South Africa Market Size and Forecast, by Product Type
8.5.6.10. South Africa Market Size and Forecast, by Delivery Mode
8.5.6.11. South Africa Market Size and Forecast, by Component
8.5.6.12. South Africa Market Size and Forecast, by End Users
8.5.6.13. Rest of LAMEA Market Size and Forecast, by Product Type
8.5.6.14. Rest of LAMEA Market Size and Forecast, by Delivery Mode
8.5.6.15. Rest of LAMEA Market Size and Forecast, by Component
8.5.6.16. Rest of LAMEA Market Size and Forecast, by End Users

CHAPTER 9: COMPANY PROFILES

9.1. ArisGlobal LLC

9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Key strategic moves and developments

9.2. Bioclinica Inc.

9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Key strategic moves and developments

9.3. Bio-Optronics Inc.

9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Key strategic moves and developments

9.4. Forte Research Systems Inc.

9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Key strategic moves and developments

9.5. IBM Corporation

9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments

9.6. Medidata Solutions Inc.

9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Business performance
9.6.4. Key strategic moves and developments

9.7. MedNet Solutions Inc.

9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Key strategic moves and developments

9.8. Oracle Corporation

9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments

9.9. PAREXEL International Corporation

9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments

9.10. Veeva Systems Inc.

9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Business performance
9.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 01. GLOBAL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 02. WEB-BASED CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 03. ON-PREMISE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 04. CLOUD-BASED CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 05. GLOBAL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 06. ENTERPRISE-BASED CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 07. SITE-BASED CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 08. GLOBAL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 09. CLINICAL TRIAL MANAGEMENT SOFTWARE MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 10. CLINICAL TRIAL MANAGEMENT HARDWARE MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 11. CLINICAL TRIAL MANAGEMENT SERVICES MARKET REVENUE, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 13. CLINICAL TRIAL MANAGEMENT MARKET REVENUE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2016-2023 ($MILLION)
TABLE 14. CLINICAL TRIAL MANAGEMENT MARKET REVENUE BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2016-2023 ($MILLION)
TABLE 15. CLINICAL TRIAL MANAGEMENT MARKET REVENUE BY HEALTHCARE PROVIDERS, BY REGION, 2016-2023 ($MILLION)
TABLE 16. CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY GEOGRAPHY, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 20. NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 21. NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 22. U.S. CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 23. U.S. CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 24. U.S. CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 25. U.S. CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 26. CANADA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 27. CANADA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 28. CANADA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 29. CANADA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 30. MEXICO CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 31. MEXICO CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 32. MEXICO CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 33. MEXICO CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 34. EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 35. EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 36. EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 37. EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 38. EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 39. GERMANY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 40. GERMANY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 41. GERMANY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 42. GERMANY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 43. FRANCE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 44. FRANCE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 45. FRANCE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 46. FRANCE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 47. UK CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 48. UK CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 49. UK CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 50. UK CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 51. ITALY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 52. ITALY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 53. ITALY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 54. ITALY CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 55. SPAIN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 56. SPAIN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 57. SPAIN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 58. SPAIN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 59. REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 60. REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 61. REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 62. REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 63. ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 64. ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 65. ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 66. ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 67. ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 68. JAPAN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 69. JAPAN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 70. JAPAN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 71. JAPAN CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 72. CHINA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 73. CHINA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 74. CHINA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 75. CHINA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 76. AUSTRALIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 77. AUSTRALIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 78. AUSTRALIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 79. AUSTRALIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 80. INDIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 81. INDIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 82. INDIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 83. INDIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 84. SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 85. SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 86. SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 87. SOUTH KOREA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 88. REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 89. REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 92. LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 93. LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 94. LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 95. LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 96. LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 97. BRAZIL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 98. BRAZIL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 99. BRAZIL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 100. BRAZIL CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 101. SAUDI ARABIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 102. SAUDI ARABIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 103. SAUDI ARABIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 104. SAUDI ARABIA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 105. SOUTH AFRICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 106. SOUTH AFRICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 107. SOUTH AFRICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 108. SOUTH AFRICA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 109. REST OF LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY PRODUCT TYPE, 2016-2023 ($MILLION)
TABLE 110. REST OF LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY DELIVERY MODE, 2016-2023 ($MILLION)
TABLE 111. REST OF LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY COMPONENT, 2016-2023 ($MILLION)
TABLE 112. REST OF LAMEA CLINICAL TRIAL MANAGEMENT MARKET REVENUE, BY END USERS, 2016-2023 ($MILLION)
TABLE 113. ARISGLOBAL: COMPANY SNAPSHOT
TABLE 114. BIOCLINICA: COMPANY SNAPSHOT
TABLE 115. BIO-OPTRONICS: COMPANY SNAPSHOT
TABLE 116. BIO-OPTRONICS: OPERATING SEGMENTS
TABLE 117. FORTE: COMPANY SNAPSHOT
TABLE 118. IBM: COMPANY SNAPSHOT
TABLE 119. IBM: OPERATING SEGMENTS
TABLE 120. MEDIDATA: COMPANY SNAPSHOT
TABLE 121. MEDNET: COMPANY SNAPSHOT
TABLE 122. ORACLE: COMPANY SNAPSHOT
TABLE 123. ORACLE: OPERATING SEGMENTS
TABLE 124. PAREXEL: COMPANY SNAPSHOT
TABLE 125. PAREXEL: OPERATING SEGMENTS
TABLE 126. VEEVA: COMPANY SNAPSHOT

LIST OF FIGURES

FIGURE 01. GLOBAL CLINICAL TRIAL MANAGEMENT MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP PLAYER POSITIONING, 2016
FIGURE 04. MODERATE BARGAINING POWER OF BUYERS
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. LOW THREAT OF SUBSTITUTION
FIGURE 08. COMPETITIVE RIVALRY
FIGURE 09. COMPARATIVE SHARE ANALYSIS OF WEB-BASED CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 10. COMPARATIVE SHARE ANALYSIS OF ON-PREMISE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CLOUD-BASED CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENTERPRISE-BASED CLINICAL TRIAL MANAGEMENT MARKET FOR MAJOR DEPRESSIVE DISORDER, BY COUNTRY, 2016 & 2023 (%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF SITE-BASED CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL MANAGEMENT SOFTWARE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL MANAGEMENT HARDWARE MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL MANAGEMENT SERVICES MARKET, BY COUNTRY, 2016 & 2023 (%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL MANAGEMENT MARKET BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2016 & 2023 (%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL MANAGEMENT MARKET BY CLINICAL RESEARCH ORGANIZATIONS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF CLINICAL TRIAL MANAGEMENT MARKET BY HEALTHCARE PROVIDERS, BY COUNTRY, 2016 & 2023 (%)
FIGURE 20. IBM: NET SALES, 2014-2016 ($MILLION)
FIGURE 21. ORACLE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 22. IBM: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 23. MEDIDATA: NET SALES, 2014-2016 ($MILLION)
FIGURE 24. MEDIDATA: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 25. ORACLE: NET SALES, 2015-2017 ($MILLION)
FIGURE 26. ORACLE: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 27. ORACLE: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 28. PAREXEL: NET SALES, 2014-2016 ($MILLION)
FIGURE 29. PAREXEL: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 30. PAREXEL: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 31. VEEVA: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. VEEVA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Have a question ?

Need to add more ?

Featured Readings

Get Fresh Content Delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

Get Industry Data Alerts >